Effectiveness-Implementation Evaluation of Acute Kidney Injury Decision Support
Recruiting
Observational Study
Acute Kidney Injury
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 and older
- Sex
- Any
- Study type
- Observational
- Participants needed
- 200,000 (estimated)
- Sponsor
- Johns Hopkins University · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Study Purpose: This study is testing an artificial intelligence (AI)-powered clinical decision support (CDS) system designed to help emergency department (ED) doctors detect and manage acute kidney injury (AKI) earlier. The goal is to see whether the tool improves patient care, clinician decision-making, and hospital outcomes when used in real-world ED settings.
Study Design:
The AI tool will be…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
Participants must meet all of the following conditions to be eligible for the study:
1. Emergency Department Visit
Patients presenting to one of the three study site emergency departments (EDs):
Johns Hopkins Hospital (JHH) Bayview Medical Center (BMC) Howard County Gen…
Contacts